Clinical Trial Update: A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in Emotions [Phase 1]

View source ↗

Summary

A Phase 1 study sponsored by Boehringer Ingelheim evaluating BI 1358894 in adults with major depressive disorder to examine effects on brain regions involved in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• BI-1358894

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED | Results posted: 2025-02-25